An exemplary tissue detection and location identification apparatus can include, for example, a first electrically conductive layer at least partially (e.g., circumferentially) surrounding a lumen, an insulating layer at least partially (e.g., circumferentially) surrounding the first electrically conductive layer, and a second electrically conductive layer circumferentially surrounding the insulating layer, where the insulating layer can electrically isolate the first electrically conductive layer from the second electrically conductive layer. A further insulating layer can be included which can at least partially surrounding the second electrically conductive layer. The first electrically conductive layer, the insulating layer, and the second electrically conductive layer can form a structure which has a first side and a second side disposed opposite to the first side with respect to the lumen, where the first side can be longer than the second side thereby forming a sharp pointed end via the first side at a distal-most portion. The exemplary configuration can be used for (a) determination/detection of a tissue type rising impendence of the electrically conductive layers, and/or (ii) determination of a location of at least one portion of the insertion device/apparatus. Another exemplary apparatus can include, for example, a base structure comprising a lumen extending along a length thereof, and at least one optically-transmissive layer circumferentially surrounding the base structure and provided at least at a distal end of the base structure. For example, in operation, the optically-transmissive layer can be configured to transmit a particular optical radiation at the distal end thereof toward a target tissue.

System for determining heart failure indicator indicative of a heart failure disease state in a subject, including processing device(s) that at least in part control signal generator(s) and receives an indication of a measured response signal from sensor(s) allowing first and second impedance measurement(s) to be performed across at least one body segment, determines a first fluid level indicator using first impedance value(s) obtained by performing the first impedance measurement(s), the first fluid indicator being indicative of a first ratio of ECF to TBW at a first time, determines a second fluid level indicator using second impedance value(s) obtained by performing the second impedance measurement(s), the second fluid indicator being indicative of a second ratio of ECF to TBW at a second time, determines a fluid level change using a difference in the first and second fluid level indicators, and, determines the heart failure indicator using the fluid level change.

A health care management system for geospatial biosurveillance including a bioimpedance device. The health care management system provides real time data and analysis of an individual's physiological condition using bioimpedance data. The health care management system is further operable to monitor and model disease progression and remission based on physiological conditions during a pandemic event as well as modeling the treatment and remediation of long-lasting physiological symptoms and organ damage due to post-acute sequelae of SARS-CoV2 infection (PASC).

A medical imaging device configured to spatially resolve recording of multispectral video data of an examination area of a patient including a light source having multiple optical emitters with different wavelengths in the visible and NIR spectral range. The light source has an emitter whose wavelength lies in the range of ±50% of its half-width around the intersection of the blue and green filter curves or the green and red filter curves, and the exposure control and the data processing means are arranged to separately detect the affected two of the red and green or the green and blue colour signals in an exposure pattern with activation of the emitter at the intersection point and to evaluate them in the multispectral analysis with mutually different wavelengths shifted by the two affected filter curves as two supporting point wavelengths.

Disclosed is an optical coherence tomography (OCT) system according to an exemplary embodiment of the present disclosure. The OCT system may include: a light source unit generating light; an optical interferometer including an optical coupler splitting the light generated by the light source unit into first distribution light and second distribution light, a reference arm reflecting the first distribution light, a sample arm reflecting the second distribution light, and an optical detector detecting the light reflected by the reference arm and the sample arm; an OCT catheter including an optical fiber having a shape in which the optical fiber is insertable into at least a part of a human body and is rotatable and discharging the light to a tissue and collecting OCT data for the tissue; an OCT engine including a processor and a storage unit and processing the OCT data collected by the OCT catheter; and an OCT controller connected to a proximal end of the OCT catheter and controlling rotation of the OCT catheter.

A system comprises of a pulse oximeter and diffusing wave spectroscopy (DWS) apparatus to perform pulse oximetry measurements. To calculate oxygen saturation, the pulse oximeter utilizes a pulse wave which is measured by an apparatus other than the pulse oximeter itself. In one embodiment, the different apparatus mentioned above is the diffusing wave spectroscopy (DWS) apparatus.

A method for use in determining fluid levels within a subject, the method including, in a processing device, determining at least one impedance value measured for the subject, determining physical dimensions for at least part of at least one segment of the subject, using the physical dimensions to determine a shape factor at least partially indicative of a shape of the at least one segment and calculating a fluid indicator indicative of the fluid levels in the segment at least in part using the at least one impedance value and the shape factor.

Methods of fluid assessment and treatment, which may include measuring a quantitative relaxation time (T2) of a muscle of a patient to determine whether the patient is hypovolemic, euvolemic, or hypervolemic. Methods of treatment may include determining a first fluid status of a patient by measuring a first quantitative relaxation time (T2) of a muscle of the patient, and administering to the patient a fluid reduction treatment or a hydration treatment.

The terminal includes a touch panel including first electrodes arranged in a first direction and second electrodes arranged in the second direction intersecting the first direction, a display panel attached to the touch panel and to display an image, and a processor to control the touch panel and the display panel. In a measuring mode, the processor is configured to: apply a driving signal to the touch panel, the touch panel being configured to form an electric field and/or magnetic field when the driving signal is applied, and determine body composition of a user based on a sensing signal output from the touch panel in accordance with eddy current, the eddy current being induced to a body of the user by the electric field and/or magnetic field formed around the touch panel.

An exemplary tissue detection and location identification apparatus can include, for example, a first electrically conductive layer at least partially (e.g., circumferentially) surrounding a lumen, an insulating layer at least partially (e.g., circumferentially) surrounding the first electrically conductive layer, and a second electrically conductive layer circumferentially surrounding the insulating layer, where the insulating layer can electrically isolate the first electrically conductive layer from the second electrically conductive layer. A further insulating layer can be included which can at least partially surrounding the second electrically conductive layer. The first electrically conductive layer, the insulating layer, and the second electrically conductive layer can form a structure which has a first side and a second side disposed opposite to the first side with respect to the lumen, where the first side can be longer than the second side thereby forming a sharp pointed end via the first side at a distal-most portion. The exemplary configuration can be used for (a) determination/detection of a tissue type using impendence of the electrically conductive layers, and/or (ii) determination of a location of at least one portion of the insertion device/apparatus. Another exemplary apparatus can include, for example, a base structure comprising a lumen extending along a length thereof, and at least one optically-transmissive layer circumferentially surrounding the base structure and provided at least at a distal end of the base structure. For example, in operation, the optically-transmissive layer can be configured to transmit a particular optical radiation at the distal end thereof toward a target tissue.